Logo image of CATB

Catabasis Pharma (CATB) Stock Analyst Earnings Estimates

NASDAQ:CATB - Nasdaq -

8.54  -0.64 (-6.97%)

After market: 8.63 +0.09 (+1.05%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Revenue
YoY % growth
EBITDA
YoY % growth
EBIT
YoY % growth
Operating Margin
EPS
YoY % growth

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

Recent Earnings VS Estimates Surprises ()
PeriodReportedEstimateDifferenceSurprise
CATB Yearly EPS VS EstimatesCATB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200
Recent Revenue VS Estimates Surprises

Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .

PeriodReportedEstimateDifferenceSurprise
CATB Yearly Revenue VS EstimatesCATB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 100K 200K 300K
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A